GO.ID,Term,Annotated,Significant,Expected,Rank in p.value_classic,p.value_elim,p.value_classic,padj_BY_elim,genes
GO:0006396,RNA processing,1129,63,23.17,3,2.4e-13,2.4e-13,1.5441398794268747e-8,"CCNB1,CWC27,EXOSC9,HABP4,HENMT1,HSPA1A,KTI12,NAF1,NSUN3,RNU6ATAC,RPPH1,SCARNA16,SCARNA2,SNORA10,SNORA18,SNORA25,SNORA26,SNORA27,SNORA28,SNORA30,SNORA31,SNORA4,SNORA40,SNORA44,SNORA48,SNORA51,SNORA53,SNORA56,SNORA57,SNORA58,SNORA62,SNORA63,SNORA64,SNORA71B,SNORA75,SNORA77,SNORA7B,SNORA8,SNORA81,SNORA84,SNORD15A,SNORD15B,SNORD22,SNORD26,SNORD29,SNORD32A,SNORD35A,SNORD47,SNORD55,SNORD58C,SNORD59B,SNORD63,SNORD67,SNORD69,SNORD76,SNORD77,SNORD79,SNORD8,SNORD80,SNORD83B,SNORD84,SNORD98,SNORD99"
GO:0051301,cell division,560,42,11.49,4,2.2e-11,3.5e-13,7.07730778070651e-7,"BIRC5,BUB1,BUB1B,CCNA1,CCNA2,CCNB1,CCNB2,CCNB3,CDC20,CDC25C,CDCA3,CDCA5,CDCA8,CDK1,CENPW,CHEK2,CKS2,FBXO5,ING2,KATNA1,KIF20A,KIF23,KIFC1,MAD2L1,NCAPG,NDC80,NUSAP1,OIP5,PLK1,PRC1,PTTG1,RACGAP1,REEP4,SPC24,STMN1,TACC3,TOP2A,TPX2,UBE2C,VRK1,ZNF16,ZWINT"
GO:0007077,mitotic nuclear envelope disassembly,12,5,0.25,51,2.5e-6,2.5e-6,0.05361596803565538,"CCNB1,CCNB2,CDK1,PLK1,VRK1"
GO:0090307,mitotic spindle assembly,54,10,1.11,36,4.6e-6,1.2e-7,0.07399003588920441,"BIRC5,CDC20,CHEK2,HSPA1A,HSPA1B,KIF23,KIFC1,PLK1,RACGAP1,TPX2"
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,99,11,2.03,54,5.8e-6,5.8e-6,0.07463342750563229,"CCNA1,CCNA2,CCNB1,CCNB2,CCNB3,CDC25C,CDKN1C,CDKN2D,CDKN3,CKS2,PLK1"
GO:0031145,anaphase-promoting complex-dependent catabolic process,80,9,1.64,67,3.7e-5,3.7e-5,0.32973820341928056,"BUB1B,CCNB1,CDC20,CDK1,FBXO5,MAD2L1,PLK1,PTTG1,UBE2C"
GO:0007052,mitotic spindle organization,101,17,2.07,11,3.8e-5,2.3e-11,0.32973820341928056,"BIRC5,CCNB1,CDC20,CHEK2,HSPA1A,HSPA1B,KIF23,KIFC1,NDC80,PLK1,POC1A,PRC1,RACGAP1,STMN1,TACC3,TPX2,TTK"
GO:0007094,mitotic spindle assembly checkpoint,34,8,0.7,42,4.1e-5,3.3e-7,0.32973820341928056,"BUB1,BUB1B,CCNB1,CDC20,MAD2L1,NDC80,PLK1,TTK"
GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,54,7,1.11,75,1.1e-4,1.1e-4,0.7863675311896122,"APOA1,CHUK,HSPA1A,HSPA1B,SPHK1,TNF,TRAIP"
GO:0045648,positive regulation of erythrocyte differentiation,30,5,0.62,87,3.3e-4,3.3e-4,1,"GATA2,HMGB2,HSPA1A,HSPA1B,ZNF16"
GO:0051231,spindle elongation,10,3,0.21,97,9.2e-4,9.2e-4,1,"KIF23,PRC1,RACGAP1"
GO:0007127,meiosis I,100,8,2.05,99,0.00105,0.00105,1,"CCNA1,CKS2,FBXO5,ING2,PLK1,PTTG1,RAD51,TOP2A"
GO:0055091,phospholipid homeostasis,11,3,0.23,100,0.00125,0.00125,1,"APOA1,FABP3,TLCD1"
GO:0002719,negative regulation of cytokine production involved in immune response,24,4,0.49,102,0.00134,0.00134,1,"APOA1,HFE,SMAD7,TNF"
GO:0030325,adrenal gland development,25,4,0.51,104,0.00157,0.00157,1,"APOA1,CDKN1C,NR0B1,PDGFRA"
GO:1904668,positive regulation of ubiquitin protein ligase activity,12,3,0.25,105,0.00164,0.00164,1,"CDC20,PLK1,UBE2C"
GO:0007080,mitotic metaphase plate congression,43,5,0.88,107,0.0018,0.0018,1,"CCNB1,CDCA5,CDCA8,KIFC1,NDC80"
GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,27,4,0.55,108,0.00211,0.00211,1,"CCNB1,CDC25C,CDK1,FBXO5"
GO:0007143,female meiotic nuclear division,27,4,0.55,109,0.00211,0.00211,1,"FBXO5,PLK1,TOP2A,TTK"
GO:1902969,mitotic DNA replication,14,3,0.29,114,0.00264,0.00264,1,"CDC45,CHEK2,RAD51"
GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,14,3,0.29,115,0.00264,0.00264,1,"CCNB1,MAD2L1,NDC80"
GO:1901889,negative regulation of cell junction assembly,29,4,0.6,119,0.00276,0.00276,1,"DKK1,EPHA7,FAM107A,TNF"
GO:0030261,chromosome condensation,31,6,0.64,65,0.00318,3.4e-5,1,"CCNB1,CDCA5,CDK1,NCAPG,NUSAP1,TOP2A"
GO:0034501,protein localization to kinetochore,15,3,0.31,127,0.00325,0.00325,1,"CDK1,NDC80,TTK"
GO:0000281,mitotic cytokinesis,71,6,1.46,129,0.00334,0.00334,1,"KIF20A,KIF23,NUSAP1,PLK1,RACGAP1,STMN1"
GO:0045840,positive regulation of mitotic nuclear division,50,5,1.03,135,0.00352,0.00352,1,"CDCA5,DLGAP5,NUSAP1,SPHK1,UBE2C"
GO:0045132,meiotic chromosome segregation,73,6,1.5,136,0.00384,0.00384,1,"BUB1,BUB1B,PLK1,PTTG1,TOP2A,TTK"
GO:2000816,negative regulation of mitotic sister chromatid separation,39,10,0.8,21,0.00386,4.4e-9,1,"BUB1,BUB1B,CCNB1,CDC20,FBXO5,MAD2L1,NDC80,PLK1,PTTG1,TTK"
GO:0007076,mitotic chromosome condensation,16,3,0.33,137,0.00394,0.00394,1,"CDCA5,NCAPG,NUSAP1"
GO:0090083,regulation of inclusion body assembly,16,3,0.33,138,0.00394,0.00394,1,"HSPA1A,HSPA1B,SNCAIP"
GO:0006266,DNA ligation,16,3,0.33,139,0.00394,0.00394,1,"HMGB2,RAD51,TOP2A"
GO:0051444,negative regulation of ubiquitin-protein transferase activity,16,3,0.33,140,0.00394,0.00394,1,"FBXO5,MAD2L1,SMAD7"
GO:0040001,establishment of mitotic spindle localization,32,4,0.66,141,0.00398,0.00398,1,"MAD2L1,NDC80,NUSAP1,PLK1"
GO:0007062,sister chromatid cohesion,52,5,1.07,142,0.00417,0.00417,1,"BUB1,BUB1B,CDC20,CDCA5,PLK1"
GO:2000272,negative regulation of signaling receptor activity,53,5,1.09,144,0.00453,0.00453,1,"DKK1,HFE,IL18BP,MTRNR2L2,MTRNR2L8"
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",54,5,1.11,145,0.00491,0.00491,1,"BTG2,CCNB1,CDC25C,CDK1,CHEK2"
GO:0016572,histone phosphorylation,35,4,0.72,151,0.00553,0.00553,1,"CCNA2,CCNB1,CDK1,VRK1"
GO:0019433,triglyceride catabolic process,35,4,0.72,152,0.00553,0.00553,1,"AADAC,APOA1,FABP3,FABP6"
GO:0060192,negative regulation of lipase activity,18,3,0.37,153,0.00556,0.00556,1,"ANXA8L1,APOA1,RGS2"
GO:0007096,regulation of exit from mitosis,19,3,0.39,160,0.00651,0.00651,1,"CDCA5,CDKN1C,UBE2C"
GO:0000070,mitotic sister chromatid segregation,144,21,2.96,7,0.00698,1.8e-12,1,"BUB1,BUB1B,CCNB1,CDC20,CDCA5,CDCA8,DLGAP5,FBXO5,KIF23,KIFC1,MAD2L1,NCAPG,NDC80,NUSAP1,PLK1,PRC1,PTTG1,RACGAP1,TACC3,TTK,ZWINT"
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,54,11,1.11,25,0.00711,1e-8,1,"BUB1,BUB1B,CCNB1,CDC20,DLGAP5,FBXO5,MAD2L1,NDC80,PLK1,TACC3,TTK"
GO:1901673,regulation of mitotic spindle assembly,20,3,0.41,166,0.00754,0.00754,1,"HSPA1A,HSPA1B,PLK1"
GO:0065004,protein-DNA complex assembly,169,9,3.47,171,0.00827,0.00827,1,"CDC45,CENPM,CENPW,GMNN,HMGB2,NAP1L3,OIP5,RAD51,RAD52"
GO:0055123,digestive system development,140,8,2.87,172,0.00834,0.00834,1,"CCNB1,CDKN1C,PDGFRA,RET,SIX2,SPDEF,TNF,XBP1"
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,116,7,2.38,179,0.01,0.01,1,"HFE,HSPA1A,HSPA1B,PBK,PLK1,RNF180,SMAD7"
GO:0015701,bicarbonate transport,42,4,0.86,182,0.01057,0.01057,1,"CA2,CA4,CA6,SLC26A1"
GO:2000104,negative regulation of DNA-dependent DNA replication,23,3,0.47,184,0.0112,0.0112,1,"CHEK2,FBXO5,GMNN"
GO:0006334,nucleosome assembly,68,5,1.4,189,0.01285,0.01285,1,"CENPM,CENPW,HMGB2,NAP1L3,OIP5"
GO:0055024,regulation of cardiac muscle tissue development,94,6,1.93,190,0.01287,0.01287,1,"CCNB1,CDK1,DKK1,MIR25,MIR499A,RGS2"
GO:2001021,negative regulation of response to DNA damage stimulus,69,5,1.42,192,0.01362,0.01362,1,"CDKN2D,CHEK2,FBXO5,ING2,RNF169"
GO:0061641,CENP-A containing chromatin organization,25,3,0.51,193,0.01411,0.01411,1,"CENPM,CENPW,OIP5"
GO:0034080,CENP-A containing nucleosome assembly,25,3,0.51,194,0.01411,0.01411,1,"CENPM,CENPW,OIP5"
GO:0050764,regulation of phagocytosis,96,6,1.97,195,0.01417,0.01417,1,"APOA1,FGR,GATA2,IL2RG,SPHK1,TNF"
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,46,4,0.94,196,0.01446,0.01446,1,"HSPA1A,HSPA1B,RET,TNF"
GO:0007283,spermatogenesis,501,18,10.28,202,0.01572,0.01572,1,"ACRBP,CCNA1,CCNB1,CDC25C,FAM9B,HMGB2,ING2,KIFC1,NR0B1,PACRG,POC1A,PTTG1,RACGAP1,RGS2,SPA17,SPINK2,VCX,ZNF296"
GO:0030278,regulation of ossification,189,9,3.88,204,0.01629,0.01629,1,"DKK1,EGR2,FBXO5,GDPD2,ID1,ID3,S1PR1,SIX2,TNF"
GO:1904666,regulation of ubiquitin protein ligase activity,22,5,0.45,71,0.0167,7e-5,1,"CDC20,FBXO5,MAD2L1,PLK1,UBE2C"
GO:0051445,regulation of meiotic cell cycle,48,4,0.99,205,0.0167,0.0167,1,"CDC20,CDC25C,FBXO5,TTK"
GO:2001020,regulation of response to DNA damage stimulus,190,9,3.9,206,0.0168,0.0168,1,"CDKN2D,CHEK2,FBXO5,FEM1B,HDAC10,ING2,RAD51,RAD52,RNF169"
GO:0033327,Leydig cell differentiation,10,2,0.21,207,0.01695,0.01695,1,"NR0B1,PDGFRA"
GO:1903862,positive regulation of oxidative phosphorylation,10,2,0.21,208,0.01695,0.01695,1,"CCNB1,CDK1"
GO:0007084,mitotic nuclear envelope reassembly,10,2,0.21,209,0.01695,0.01695,1,"REEP4,VRK1"
GO:0070431,nucleotide-binding oligomerization domain containing 2 signaling pathway,10,2,0.21,210,0.01695,0.01695,1,"HSPA1A,HSPA1B"
GO:0071281,cellular response to iron ion,10,2,0.21,211,0.01695,0.01695,1,"CCNB1,HFE"
GO:0051255,spindle midzone assembly,10,2,0.21,212,0.01695,0.01695,1,"KIF23,RACGAP1"
GO:0003376,sphingosine-1-phosphate receptor signaling pathway,10,2,0.21,213,0.01695,0.01695,1,"S1PR1,SPHK1"
GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle,27,3,0.55,214,0.01741,0.01741,1,"CCNA1,CDC45,FBXO5"
GO:0031055,chromatin remodeling at centromere,27,3,0.55,215,0.01741,0.01741,1,"CENPM,CENPW,OIP5"
GO:1901989,positive regulation of cell cycle phase transition,102,9,2.09,83,0.01823,2.5e-4,1,"CCNB1,CDC25C,CDC45,CDCA5,CDK1,DLGAP5,FBXO5,UBE2C,ZNF16"
GO:0018105,peptidyl-serine phosphorylation,293,12,6.01,219,0.01829,0.01829,1,"CCNB1,CDK1,CHEK2,CHUK,DKK1,PLK1,RET,SMAD7,STK32C,TNF,TTK,VRK1"
GO:0048146,positive regulation of fibroblast proliferation,50,4,1.03,220,0.01915,0.01915,1,"CCNA2,CCNB1,PDGFRA,SPHK1"
GO:0001101,response to acid chemical,330,13,6.77,221,0.0192,0.0192,1,"CCNB1,CDKN2D,CHUK,DKK1,FABP3,ID3,MICB,PDGFRA,PTGER2,RET,SCD,TNF,XBP1"
GO:0008608,attachment of spindle microtubules to kinetochore,28,3,0.57,222,0.01921,0.01921,1,"CCNB1,NDC80,RACGAP1"
GO:0000132,establishment of mitotic spindle orientation,28,3,0.57,223,0.01921,0.01921,1,"MAD2L1,NDC80,PLK1"
GO:0006275,regulation of DNA replication,103,6,2.11,224,0.01942,0.01942,1,"CCNA2,CDK1,CHEK2,FBXO5,GMNN,ID3"
GO:1902571,regulation of serine-type peptidase activity,11,2,0.23,226,0.02044,0.02044,1,"ANXA8L1,SPINK2"
GO:1900003,regulation of serine-type endopeptidase activity,11,2,0.23,227,0.02044,0.02044,1,"ANXA8L1,SPINK2"
GO:0090084,negative regulation of inclusion body assembly,11,2,0.23,228,0.02044,0.02044,1,"HSPA1A,HSPA1B"
GO:0035404,histone-serine phosphorylation,11,2,0.23,229,0.02044,0.02044,1,"CCNB1,VRK1"
GO:0045835,negative regulation of meiotic nuclear division,11,2,0.23,230,0.02044,0.02044,1,"FBXO5,TTK"
GO:0000185,activation of MAPKKK activity,11,2,0.23,231,0.02044,0.02044,1,"GADD45G,TNF"
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,77,5,1.58,232,0.021,0.021,1,"HSPA1A,HSPA1B,PLK1,RNF180,SMAD7"
GO:0048232,male gamete generation,518,18,10.63,233,0.02122,0.02122,1,"ACRBP,CCNA1,CCNB1,CDC25C,FAM9B,HMGB2,ING2,KIFC1,NR0B1,PACRG,POC1A,PTTG1,RACGAP1,RGS2,SPA17,SPINK2,VCX,ZNF296"
GO:0051085,chaperone cofactor-dependent protein refolding,30,3,0.62,236,0.02311,0.02311,1,"HSPA1A,HSPA1B,HSPA6"
GO:0007274,neuromuscular synaptic transmission,30,3,0.62,237,0.02311,0.02311,1,"CHRNA1,CHRNB4,P2RX3"
GO:0090520,sphingolipid mediated signaling pathway,12,2,0.25,238,0.0242,0.0242,1,"S1PR1,SPHK1"
GO:0006068,ethanol catabolic process,12,2,0.25,239,0.0242,0.0242,1,"ALDH3B2,SULT1E1"
GO:0051988,regulation of attachment of spindle microtubules to kinetochore,12,2,0.25,240,0.0242,0.0242,1,"CCNB1,RACGAP1"
GO:0060394,negative regulation of pathway-restricted SMAD protein phosphorylation,12,2,0.25,241,0.0242,0.0242,1,"DKK1,SMAD7"
GO:0010454,negative regulation of cell fate commitment,12,2,0.25,242,0.0242,0.0242,1,"DKK1,SPDEF"
GO:0051798,positive regulation of hair follicle development,12,2,0.25,243,0.0242,0.0242,1,"FST,TNF"
GO:0040020,regulation of meiotic nuclear division,31,3,0.64,246,0.0252,0.0252,1,"CDC20,FBXO5,TTK"
GO:0060325,face morphogenesis,31,3,0.64,247,0.0252,0.0252,1,"CRISPLD1,DKK1,PDGFRA"
GO:0097194,execution phase of apoptosis,82,5,1.68,252,0.02672,0.02672,1,"HMGB2,MTRNR2L2,MTRNR2L8,TOP2A,XKR8"
GO:0010872,regulation of cholesterol esterification,13,2,0.27,255,0.02822,0.02822,1,"APOA1,MIR27B"
GO:0042635,positive regulation of hair cycle,13,2,0.27,256,0.02822,0.02822,1,"FST,TNF"
GO:1900121,negative regulation of receptor binding,13,2,0.27,257,0.02822,0.02822,1,"HFE,MIR27B"
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,143,7,2.94,258,0.02825,0.02825,1,"HFE,HSPA1A,HSPA1B,PBK,PLK1,RNF180,SMAD7"
GO:0018209,peptidyl-serine modification,313,12,6.42,259,0.02868,0.02868,1,"CCNB1,CDK1,CHEK2,CHUK,DKK1,PLK1,RET,SMAD7,STK32C,TNF,TTK,VRK1"
GO:0048566,embryonic digestive tract development,33,3,0.68,260,0.02969,0.02969,1,"PDGFRA,SIX2,TNF"
GO:0006336,DNA replication-independent nucleosome assembly,33,3,0.68,261,0.02969,0.02969,1,"CENPM,CENPW,OIP5"
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,33,3,0.68,262,0.02969,0.02969,1,"CDKN1C,CDKN2D,PLK1"
GO:0070542,response to fatty acid,85,5,1.74,264,0.03059,0.03059,1,"CCNB1,FABP3,ID3,PTGER2,SCD"
GO:0034724,DNA replication-independent nucleosome organization,34,3,0.7,266,0.03208,0.03208,1,"CENPM,CENPW,OIP5"
GO:0051084,'de novo' posttranslational protein folding,34,3,0.7,267,0.03208,0.03208,1,"HSPA1A,HSPA1B,HSPA6"
GO:1904030,negative regulation of cyclin-dependent protein kinase activity,34,3,0.7,268,0.03208,0.03208,1,"CDKN1C,CDKN2D,PLK1"
GO:0051294,establishment of spindle orientation,34,3,0.7,269,0.03208,0.03208,1,"MAD2L1,NDC80,PLK1"
GO:0001675,acrosome assembly,14,2,0.29,270,0.03248,0.03248,1,"ACRBP,SPINK2"
GO:2000303,regulation of ceramide biosynthetic process,14,2,0.29,271,0.03248,0.03248,1,"SPHK1,TNF"
GO:0002070,epithelial cell maturation,14,2,0.29,272,0.03248,0.03248,1,"FEM1B,XBP1"
GO:0048313,Golgi inheritance,14,2,0.29,273,0.03248,0.03248,1,"CDK1,VRK1"
GO:0048308,organelle inheritance,14,2,0.29,274,0.03248,0.03248,1,"CDK1,VRK1"
GO:0090153,regulation of sphingolipid biosynthetic process,14,2,0.29,275,0.03248,0.03248,1,"SPHK1,TNF"
GO:1905038,regulation of membrane lipid metabolic process,14,2,0.29,276,0.03248,0.03248,1,"SPHK1,TNF"
GO:0007501,mesodermal cell fate specification,14,2,0.29,277,0.03248,0.03248,1,"DKK1,SIX2"
GO:0055012,ventricular cardiac muscle cell differentiation,14,2,0.29,278,0.03248,0.03248,1,"CCNB1,CDK1"
GO:0051272,positive regulation of cellular component movement,545,18,11.19,279,0.03284,0.03284,1,"F10,FAM107A,FAM110C,FBXO5,FGFR1OP,FGR,GATA2,MALAT1,MIR27B,MIR499A,PDGFRA,RET,S1PR1,SPHK1,STMN1,TAC4,TNF,XBP1"
GO:1901099,negative regulation of signal transduction in absence of ligand,35,3,0.72,281,0.03457,0.03457,1,"HSPA1A,HSPA1B,TNF"
GO:0034508,centromere complex assembly,35,3,0.72,282,0.03457,0.03457,1,"CENPM,CENPW,OIP5"
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,35,3,0.72,283,0.03457,0.03457,1,"HSPA1A,HSPA1B,TNF"
GO:0032465,regulation of cytokinesis,88,5,1.81,284,0.0348,0.0348,1,"KIF20A,KIF23,PLK1,PRC1,RACGAP1"
GO:1901992,positive regulation of mitotic cell cycle phase transition,88,8,1.81,89,0.03534,4.5e-4,1,"CCNB1,CDC25C,CDC45,CDCA5,CDK1,DLGAP5,FBXO5,UBE2C"
GO:0043306,positive regulation of mast cell degranulation,15,2,0.31,287,0.03698,0.03698,1,"FGR,GATA2"
GO:0002739,regulation of cytokine secretion involved in immune response,15,2,0.31,288,0.03698,0.03698,1,"APOA1,TNF"
GO:0034310,primary alcohol catabolic process,15,2,0.31,289,0.03698,0.03698,1,"ALDH3B2,SULT1E1"
GO:0033008,positive regulation of mast cell activation involved in immune response,15,2,0.31,290,0.03698,0.03698,1,"FGR,GATA2"
GO:0060323,head morphogenesis,36,3,0.74,291,0.03716,0.03716,1,"CRISPLD1,DKK1,PDGFRA"
GO:0044070,regulation of anion transport,90,5,1.85,292,0.03779,0.03779,1,"APOA1,CA2,CYP4A11,FABP3,RGS2"
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,62,4,1.27,293,0.03838,0.03838,1,"DKK1,HFE,SMAD7,TTK"
GO:0018107,peptidyl-threonine phosphorylation,121,6,2.48,294,0.03864,0.03864,1,"CDK1,PLK1,SMAD7,SPHK1,TTK,VRK1"
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,91,5,1.87,295,0.03934,0.03934,1,"HSPA1A,HSPA1B,PLK1,RNF180,SMAD7"
GO:0045841,negative regulation of mitotic metaphase/anaphase transition,36,9,0.74,31,0.03977,3.4e-8,1,"BUB1,BUB1B,CCNB1,CDC20,FBXO5,MAD2L1,NDC80,PLK1,TTK"
GO:0008156,negative regulation of DNA replication,37,3,0.76,297,0.03984,0.03984,1,"CHEK2,FBXO5,GMNN"
GO:0006656,phosphatidylcholine biosynthetic process,37,3,0.76,298,0.03984,0.03984,1,"APOA1,CHPT1,FABP3"
GO:0044770,cell cycle phase transition,608,33,12.48,47,0.04087,3.8e-7,1,"BTG2,BUB1,BUB1B,CCNA1,CCNA2,CCNB1,CCNB2,CCNB3,CDC20,CDC25C,CDC45,CDCA5,CDK1,CDKN1C,CDKN2D,CDKN3,CHEK2,CKS2,DLGAP5,FAM107A,FBXO5,FGFR1OP,GMNN,HMMR,MAD2L1,NDC80,PLK1,PRIM1,TACC3,TPX2,TTK,UBE2C,ZNF16"
GO:0048738,cardiac muscle tissue development,223,9,4.58,301,0.0411,0.0411,1,"CCNB1,CDK1,DKK1,MIR25,MIR499A,PDGFRA,RGS2,S1PR1,SMAD7"
GO:2000001,regulation of DNA damage checkpoint,16,2,0.33,305,0.0417,0.0417,1,"CHEK2,FEM1B"
GO:0051923,sulfation,16,2,0.33,306,0.0417,0.0417,1,"CHST4,SULT1E1"
GO:0051447,negative regulation of meiotic cell cycle,16,2,0.33,307,0.0417,0.0417,1,"FBXO5,TTK"
GO:0072224,metanephric glomerulus development,16,2,0.33,308,0.0417,0.0417,1,"PDGFRA,RET"
GO:0031400,negative regulation of protein modification process,582,21,11.95,175,0.04199,0.0091,1,"AMBP,CCNB1,CDKN1C,CDKN2D,DKK1,DUSP2,FBLN1,FBXO5,FGFR1OP,HSPA1A,HSPA1B,MAD2L1,MIR106B,PBK,PLK1,PPP1R35,PRR7,PSCA,RGS2,SMAD7,TNF"
GO:0001933,negative regulation of protein phosphorylation,407,14,8.35,309,0.04207,0.04207,1,"AMBP,CCNB1,CDKN1C,CDKN2D,DKK1,DUSP2,FBLN1,FGFR1OP,MIR106B,PBK,PLK1,PSCA,RGS2,SMAD7"
GO:0044772,mitotic cell cycle phase transition,570,32,11.7,40,0.04211,2.7e-7,1,"BTG2,BUB1,BUB1B,CCNA1,CCNA2,CCNB1,CCNB2,CCNB3,CDC20,CDC25C,CDC45,CDCA5,CDK1,CDKN1C,CDKN2D,CDKN3,CHEK2,CKS2,DLGAP5,FAM107A,FBXO5,FGFR1OP,GMNN,HMMR,MAD2L1,NDC80,PLK1,PRIM1,TACC3,TPX2,TTK,UBE2C"
GO:0006458,'de novo' protein folding,38,3,0.78,311,0.04262,0.04262,1,"HSPA1A,HSPA1B,HSPA6"
GO:0045995,regulation of embryonic development,124,6,2.55,312,0.04271,0.04271,1,"APOA1,CDK1,DKK1,GATA2,GORAB,RACGAP1"
GO:0090068,positive regulation of cell cycle process,287,18,5.89,64,0.04345,2.8e-5,1,"BTG2,CCNB1,CDC25C,CDC45,CDCA5,CDK1,CHEK2,DLGAP5,FBXO5,KIF23,MAD2L1,NDC80,NUSAP1,POC1A,RACGAP1,SPHK1,UBE2C,ZNF16"
GO:0031396,regulation of protein ubiquitination,188,13,3.86,78,0.04401,1.4e-4,1,"CDC20,FAM107A,FBXO5,FEM1B,HSPA1A,HSPA1B,MAD2L1,PLK1,PRR7,RNF180,SMAD7,SPHK1,UBE2C"
GO:0050909,sensory perception of taste,65,4,1.33,316,0.04444,0.04444,1,"AZGP1,CA6,GNG13,P2RX3"
GO:0060389,pathway-restricted SMAD protein phosphorylation,65,4,1.33,317,0.04444,0.04444,1,"DKK1,HFE,SMAD7,TTK"
GO:0044843,cell cycle G1/S phase transition,283,14,5.81,110,0.0445,0.00222,1,"BTG2,CCNA1,CCNA2,CCNB1,CDC25C,CDC45,CDK1,CDKN2D,CDKN3,CHEK2,FAM107A,FBXO5,GMNN,PRIM1"
GO:0030071,regulation of mitotic metaphase/anaphase transition,51,10,1.05,33,0.04485,7e-8,1,"BUB1,BUB1B,CCNB1,CDC20,DLGAP5,FBXO5,MAD2L1,NDC80,PLK1,TTK"
GO:0032506,cytokinetic process,39,3,0.8,320,0.04549,0.04549,1,"KIF20A,KIF23,RACGAP1"
GO:0042026,protein refolding,39,3,0.8,321,0.04549,0.04549,1,"HSPA1A,HSPA1B,HSPA6"
GO:0051154,negative regulation of striated muscle cell differentiation,39,3,0.8,322,0.04549,0.04549,1,"DKK1,RGS2,XBP1"
GO:0055007,cardiac muscle cell differentiation,126,6,2.59,323,0.04556,0.04556,1,"CCNB1,CDK1,DKK1,MIR499A,PDGFRA,RGS2"
GO:1901976,regulation of cell cycle checkpoint,31,5,0.64,88,0.04597,3.9e-4,1,"CCNB1,CHEK2,FEM1B,MAD2L1,NDC80"
GO:0060236,regulation of mitotic spindle organization,37,5,0.76,96,0.046,9e-4,1,"HSPA1A,HSPA1B,PLK1,TACC3,TPX2"
GO:0002710,negative regulation of T cell mediated immunity,17,2,0.35,326,0.04664,0.04664,1,"HFE,SMAD7"
GO:0034433,steroid esterification,17,2,0.35,327,0.04664,0.04664,1,"APOA1,MIR27B"
GO:0034434,sterol esterification,17,2,0.35,328,0.04664,0.04664,1,"APOA1,MIR27B"
GO:0034435,cholesterol esterification,17,2,0.35,329,0.04664,0.04664,1,"APOA1,MIR27B"
GO:2000193,positive regulation of fatty acid transport,17,2,0.35,330,0.04664,0.04664,1,"CYP4A11,FABP3"
GO:0051023,regulation of immunoglobulin secretion,17,2,0.35,331,0.04664,0.04664,1,"TNF,XBP1"
GO:0008272,sulfate transport,17,2,0.35,332,0.04664,0.04664,1,"RACGAP1,SLC26A1"
GO:0061298,retina vasculature development in camera-type eye,17,2,0.35,333,0.04664,0.04664,1,"NDP,PDGFRA"
GO:2000147,positive regulation of cell motility,531,17,10.9,334,0.04765,0.04765,1,"F10,FAM107A,FAM110C,FBXO5,FGFR1OP,FGR,GATA2,MALAT1,MIR27B,MIR499A,PDGFRA,RET,S1PR1,SPHK1,TAC4,TNF,XBP1"
GO:0055017,cardiac muscle tissue growth,96,5,1.97,335,0.04768,0.04768,1,"CCNB1,CDK1,MIR25,RGS2,S1PR1"
GO:0043486,histone exchange,40,3,0.82,338,0.04846,0.04846,1,"CENPM,CENPW,OIP5"
GO:0009268,response to pH,40,3,0.82,339,0.04846,0.04846,1,"CA2,GNA11,HVCN1"
GO:0072210,metanephric nephron development,40,3,0.82,340,0.04846,0.04846,1,"PDGFRA,RET,SIX2"
GO:0048565,digestive tract development,128,6,2.63,341,0.04854,0.04854,1,"CCNB1,PDGFRA,RET,SIX2,SPDEF,TNF"
GO:0045598,regulation of fat cell differentiation,128,6,2.63,342,0.04854,0.04854,1,"GATA2,MIR27B,RORC,SULT1E1,TNF,XBP1"
GO:0051100,negative regulation of binding,161,7,3.3,343,0.04857,0.04857,1,"DKK1,HABP4,HFE,ID1,ID3,MIR27B,STMN1"
GO:0007276,gamete generation,646,23,13.26,167,0.04919,0.00757,1,"ACRBP,CCNA1,CCNB1,CDC25C,FAM9B,FBXO5,HMGB2,ING2,KIFC1,NR0B1,PACRG,PLK1,POC1A,PTTG1,RACGAP1,RGS2,SPA17,SPIN2A,SPINK2,TOP2A,TTK,VCX,ZNF296"
GO:0031647,regulation of protein stability,267,10,5.48,345,0.04947,0.04947,1,"APOA1,CDKN2AIP,CHEK2,FAM107A,HSPA1A,HSPA1B,ID1,PLK1,SMAD7,XBP1"
GO:0018210,peptidyl-threonine modification,129,6,2.65,348,0.05007,0.05007,1,"CDK1,PLK1,SMAD7,SPHK1,TTK,VRK1"
GO:0055026,negative regulation of cardiac muscle tissue development,41,3,0.84,350,0.05152,0.05152,1,"DKK1,MIR25,RGS2"
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,233,9,4.78,352,0.05166,0.05166,1,"CDKN1C,DKK1,FST,HFE,HSPA1A,ING2,RASL11B,SMAD7,TTK"
GO:0048557,embryonic digestive tract morphogenesis,18,2,0.37,353,0.05177,0.05177,1,"PDGFRA,SIX2"
GO:1903589,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,18,2,0.37,354,0.05177,0.05177,1,"GATA2,MIR27B"
GO:0007063,regulation of sister chromatid cohesion,18,2,0.37,355,0.05177,0.05177,1,"BUB1,CDCA5"
GO:0007064,mitotic sister chromatid cohesion,18,2,0.37,356,0.05177,0.05177,1,"CDC20,CDCA5"
GO:0051383,kinetochore organization,18,2,0.37,357,0.05177,0.05177,1,"CENPW,NDC80"
GO:0031468,nuclear envelope reassembly,18,2,0.37,358,0.05177,0.05177,1,"REEP4,VRK1"
GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,18,2,0.37,359,0.05177,0.05177,1,"HSPA1A,XBP1"
GO:0032091,negative regulation of protein binding,99,5,2.03,360,0.05315,0.05315,1,"DKK1,HFE,ID1,MIR27B,STMN1"
GO:1901800,positive regulation of proteasomal protein catabolic process,99,5,2.03,361,0.05315,0.05315,1,"HSPA1A,HSPA1B,PLK1,RNF180,SMAD7"
GO:0050766,positive regulation of phagocytosis,69,4,1.42,362,0.05331,0.05331,1,"APOA1,GATA2,IL2RG,TNF"
GO:0030866,cortical actin cytoskeleton organization,42,3,0.86,364,0.05467,0.05467,1,"KIF23,RACGAP1,TNF"
GO:1902099,regulation of metaphase/anaphase transition of cell cycle,53,10,1.09,35,0.05494,1e-7,1,"BUB1,BUB1B,CCNB1,CDC20,DLGAP5,FBXO5,MAD2L1,NDC80,PLK1,TTK"
GO:0007517,muscle organ development,386,13,7.92,367,0.05604,0.05604,1,"BTG2,CCNB1,CDK1,CHRNA1,DKK1,EGR2,ID3,MIR25,MIR499A,RGS2,S1PR1,SMAD7,XBP1"
GO:0048469,cell maturation,167,7,3.43,368,0.05698,0.05698,1,"CCNB1,CDKN1C,FBXO5,FEM1B,GATA2,RET,XBP1"
GO:0001710,mesodermal cell fate commitment,19,2,0.39,369,0.05709,0.05709,1,"DKK1,SIX2"
GO:0048670,regulation of collateral sprouting,19,2,0.39,370,0.05709,0.05709,1,"EPHA7,LPAR3"
GO:1902993,positive regulation of amyloid precursor protein catabolic process,19,2,0.39,371,0.05709,0.05709,1,"SPON1,TNF"
GO:0033005,positive regulation of mast cell activation,19,2,0.39,372,0.05709,0.05709,1,"FGR,GATA2"
GO:0002374,cytokine secretion involved in immune response,19,2,0.39,373,0.05709,0.05709,1,"APOA1,TNF"
GO:0050804,modulation of chemical synaptic transmission,426,14,8.74,374,0.05729,0.05729,1,"ARC,CA2,CDC20,CHRNB4,DKK1,EGR2,FAM107A,GRM2,NPTX1,P2RX3,SLC30A1,SNCAIP,TNF,VAMP1"
GO:0032365,intracellular lipid transport,43,3,0.88,375,0.05791,0.05791,1,"FABP3,MIR27B,THRSP"
